Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 28;15(10):e0240518.
doi: 10.1371/journal.pone.0240518. eCollection 2020.

Development of a core outcome set for use in community-based bipolar trials-A qualitative study and modified Delphi

Ameeta Retzer  1 , Ruth Sayers  2 , Vanessa Pinfold  2 , John Gibson  2   3 , Thomas Keeley  4 , Gemma Taylor  5 , Humera Plappert  3 , Bliss Gibbons  6 , Peter Huxley  7 , Jonathan Mathers  8 , Maximillian Birchwood  9   10 , Melanie Calvert  1   11
Affiliations

Development of a core outcome set for use in community-based bipolar trials-A qualitative study and modified Delphi

Ameeta Retzer et al. PLoS One. .

Abstract

Background: A core outcome set (COS) is a standardised collection of outcomes to be collected and reported in all trials within a research area. A COS can reduce reporting bias and facilitate evidence synthesis. This is currently unavailable for use in community-based bipolar trials. This research aimed to develop such a COS, with input from a full range of stakeholders.

Methods: A co-production approach was used throughout. A longlist of outcomes was derived from focus groups with people with a bipolar diagnosis and carers, interviews with healthcare professionals and a rapid review of outcomes listed in bipolar trials on the Cochrane database. An expert panel with personal and/or professional experience of bipolar participated in a modified Delphi process and the COS was finalised at a consensus meeting.

Results: Fifty participants rated the importance of each outcome. Sixty-six outcomes were included in Round 1 of the questionnaire; 13 outcomes were added by Round 1 participants and were rated in Round 2. Seventy-six percent of participants (n = 38) returned to Round 2 and 60 outcomes, including 4 outcomes added by participants in Round 1, received a rating of 7-9 by >70% and 1-3 by <25% of the sample. Fourteen participants finalised a COS containing 11 outcomes at the consensus meeting: personal recovery; connectedness; clinical recovery of bipolar symptoms; mental health and wellbeing; physical health; self-monitoring and management; medication effects; quality of life; service outcomes; experience of care; and use of coercion.

Conclusions: This COS is recommended for use in community-based bipolar trials to ensure stakeholder-relevant outcomes, facilitate data synthesis, and transparent reporting. The COS includes guidance notes for each outcome to allow the identification of suitable measurement instruments. Further validation is recommended for use with a wide range of communities and to achieve standardised measurement.

PubMed Disclaimer

Conflict of interest statement

The authors have read the journal’s policy and have the following competing interests: VP is the research director at McPin Foundation, a registered charity (1117336). She is a board member of the MRC developing mind programme, Rethink Mental Illness clinical advisory group, THIS Institute (Cambridge University) involvement and engagement panel. McPin receives funding from a variety of sources including NIHR / UKRI research grants, evaluation commissions from other charities and universities. MC receives funding from the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UK Research and Innovation), Macmillan Cancer Support, UCB Pharma and the Patient-Centered Outcomes Research Institute (PCORI). MC has received personal fees from Astellas, Daiichi Sankyo, Glaukos, Takeda, Merck, and Ferring outside the submitted work, and chairs the ISOQOL (International Society for Quality of Life Research) Best Practice for PROs in Trials Taskforce. TK is an employee of GlaxoSmithKline and completed work on this project while employed at Centre for Patient Reported Outcomes Research (CPROR), University of Birmingham (UoB). GT is currently funded by a Cancer Research UK Population Researcher Postdoctoral Fellowship award (reference: C56067/A21330). This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.

Figures

Fig 1
Fig 1. Illustration of core outcome set development process.
Fig 2
Fig 2. Overview of stakeholder involvement per phase.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Keeley T, Khan H, Pinfold V, Williamson P, Mathers J, Davies L, et al. Core outcome sets for use in effectiveness trials involving people with bipolar and schizophrenia in a community-based setting (PARTNERS2): study protocol for the development of two core outcome sets. Trials. 2015; 16:47 10.1186/s13063-015-0553-0 - DOI - PMC - PubMed
    1. World Health Organisation: International Classification of Diseases– 10 (Version: 2016)–Bipolar Affective Disorder. https://icd.who.int/browse10/2016/en#/F31 [Accessed 19.11.19].
    1. World Health Organisation: WHO releases new International Classification of Diseases (ICD 11). https://www.who.int/news-room/detail/18-06-2018-who-releases-new-interna... [Accessed 19.11.19].
    1. Laursen TM. Life expectancy with schizophrenia or bipolar affective disorder. Schizophrenia Research 2011; 131: 101–4. 10.1016/j.schres.2011.06.008 - DOI - PubMed
    1. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ 2011; 343: d5422 10.1136/bmj.d5422 - DOI - PMC - PubMed

Publication types